Clinical Trial Update: Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients

View source ↗

Summary

An observational study is evaluating the combination of selinexor with bortezomib and dexamethasone for multiple myeloma and is currently recruiting. It is spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Velcade (bortezomib)
• XPOVIO (selinexor)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Multiple Myeloma | Status: RECRUITING